Longeveron (LGVN) Debt to Equity (2021 - 2023)
Longeveron (LGVN) recorded quarterly Debt to Equity of $0.09 in Q3 2023, up 72.18% quarter-over-quarter from $0.05 in Q2 2023.
Longeveron (LGVN) Debt to Equity (2021 - 2023) Analysis & Trends
Longeveron's Debt to Equity history runs 3 years deep, the most recent figure standing at $0.09 for Q3 2023.
- In Q3 2023, Debt to Equity changed N/A year-over-year to $0.09; the TTM figure through Sep 2023 stood at $0.09 (changed N/A YoY), while the FY2022 annual figure was $0.03, up 91.86% from the prior year.
- Debt to Equity was $0.09 for Q3 2023 at Longeveron, up from $0.05 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.09 in Q3 2023 to a low of $0.01 in Q4 2021.
- Historically, Debt to Equity has averaged $0.04 across 3 years, with a median of $0.03 in 2023.
- Biggest YoY gain for Debt to Equity was 91.86% in 2022; the steepest drop was 91.86% in 2022.
- A 3-year view of Debt to Equity shows it stood at $0.01 in 2021, then surged by 91.86% to $0.03 in 2022, then jumped by 221.21% to $0.09 in 2023.
- The last three Debt to Equity figures came in at $0.09 (Q3 2023), $0.05 (Q2 2023), and $0.03 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 0.09 |
| Jun 30, 2023 | 0.05 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.03 |
| Dec 31, 2021 | 0.01 |